Advertisement
Career participation in professional American football seems not to be associated with an increased risk of all-cause mortality compared with limited participation

Mortality Risk Similar for Career Versus Limited NFL Participation

0
No significantly increased adjusted mortality risk seen for career players relative to replacements
The nutritional differences and health benefits among various plant-based alternative milks are discussed in a review published in the January issue of the Journal of Food Science and Technology.

Review Outlines Nutritional Differences in Plant-Based Milks

0
Nutrient content and health benefits of four most popular milk alternatives help consumers decide

January 2018 Briefing – Internal Medicine

0
Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for January 2018. This roundup includes the...
The number of users who exceed the daily limit of nonsteroidal anti-inflammatory drugs is "nontrivial

NSAID Users Commonly Exceed Daily Limit

0
Educating consumers about dosing directions could improve dosing compliance
Due to shared risk factors and impact on heart health from cancer treatment

AHA: Breast Cancer Patients at Increased Risk for CV Disease

0
Beyond overlapping risk factors, breast cancer treatments can have negative effect on CV health
Migraine is associated with elevated risks of myocardial infarction

Migraine Linked to Increased Risk of Cardiovascular Disease

0
Increased risks of myocardial infarction, ischemic and hemorrhagic stroke, VTE, A-fib, and flutter
Supplementation with omega-3 fatty acids is not associated with fatal or nonfatal coronary heart disease or major vascular events

Omega-3 Fatty Acids Not Found to Up Risk of Heart Disease

0
No significant association with fatal, nonfatal coronary heart disease, major vascular events
For patients with paroxysmal atrial fibrillation

Characteristics of Asymptomatic Paroxysmal A-Fib Identified

0
All-cause mortality significantly higher in asymptomatic versus symptomatic patients with PAF
Once-daily treatment with glecaprevir-pibrentasvir appears safe and effective for the treatment of hepatitis C virus genotype 1 or 3

Glecaprevir-Pibrentasvir Effective Treatment for HCV Genotypes 1, 3

0
Once-daily treatment for eight or 12 weeks yields high rates of sustained virologic response
Non-sleep specialists and sleep specialist physicians provide similar quality care with similar patient outcomes for adults with known or suspected obstructed sleep apnea

Non-Sleep Specialists May Offer Similar Quality Sleep Apnea Care

0
Findings based on review comparing OSA care by non-sleep specialists vs. sleep specialist physicians